Clinical trial

SHR7390 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

NCT04676607

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-12-17

PhasePHASE2

Study timeline

Study start (actual)2020-12-17Date precision: day

Registry last updated2023-06-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Castration-resistant Prostate Cancerunresolved

Interventions

SHR7390DRUG

Sponsors & collaborators

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical Schoollead sponsor

Mapped research locations

NanjingJiangsu, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04676607 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.